We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Ruling on BRCA Gene Patents Could Have Limited Impact.
- Authors
Goozner, Merrill
- Abstract
The article explains the perception on the limited impact of the ruling concerning gene-based patents on breast cancer (BRCA) testing. Medical experts stated that the ruling of a federal district court to invalidate the claim of Myriad Genetics on their exclusive rights to BRCA1 and BRCA2 genes could pave the way for more competition in genetic testing. Complains of researchers include the violation of their ethical obligations to the women participants in the study and the obstruction of further scientific studies on BRCA1 and BRCA2.
- Subjects
BREAST cancer; DISTRICT courts; GENES; GENETICS; MEDICAL research
- Publication
JNCI: Journal of the National Cancer Institute, 2010, Vol 102, Issue 11, p754
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djq209